Sign in
4

Changes in Ownership

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001127602-23-028965

VP, Chief Accounting Officer sold 1,013 shares at $349.00 ($353,541)

  • VP, Chief Accounting Officer acquired 797 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Winters Chad VP, Chief Accounting Officer 2023-12-01 Option exercise +456 $143.43 $65,404 1,941.7 D
Winters Chad VP, Chief Accounting Officer 2023-12-01 Sale −1,013 $349.00 $353,541 1,269.7 D
Winters Chad VP, Chief Accounting Officer 2023-12-01 Option exercise +341 $173.22 $59,068 2,282.7 D
Derivatives
Winters Chad VP, Chief Accounting Officer 2023-12-01 Option exercise · Stock Options (Right to Buy) −456 0 D
Winters Chad VP, Chief Accounting Officer 2023-12-01 Option exercise · Stock Options (Right to Buy) −341 1,571 D
Open-market sales · 1,013 sh · avg $349.00 · $353,541
Loading xslF345X05/form4.xml…